RUNX1 and neoplasm: These results conclusively demonstrate that IGF2BP1 regulates the TNFα induced NFκB and PI3K-Akt signalling pathways in ETV6::RUNX1 positive B-ALL and its inhibition leads to reduced tumor cell survival and reduced expression of these pathway targets.